Bleeding News and Research

RSS

Stimulation of single whisker prevents stroke in rats

Talk about surviving by a whisker. The most common type of stroke can be completely prevented in rats by stimulating a single whisker, according to a new study by UC Irvine researchers.

14 Jul 2010

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

As healthcare providers prepare for the implications of reform, the more than 200 hospitals participating in the QUEST: High Performing Hospitals collaborative are already achieving the goals of improving patient care and reducing costs.

13 Jul 2010

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

13 Jul 2010

Bayer HealthCare announces over $2.5M for largest awards program in hemophilia

Bayer HealthCare announced today that it awarded more than $2.5 million in funding to 19 recipients from 10 countries through its Bayer Hemophilia Awards Program (BHAP). BHAP is the largest awards program of its kind in hemophilia, providing funds that support clinical and basic research, encourage new physicians to enter the field and enable continuing education for caregivers around the world.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

12 Jul 2010

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Biogen Idec and Swedish Orphan Biovitrum today announced that they plan to advance the companies' long-lasting, fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) into a registrational clinical trial in people with hemophilia A. The decision to advance the program is based on promising data from a Phase 1/2a open-label, cross-over, multi-center, dose-escalation study that evaluated the safety and pharmacokinetics of an intravenous injection of rFVIIIFc in 16 previously-treated patients with severe hemophilia A.

12 Jul 2010

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.

12 Jul 2010

Serum BNP do not increase in pediatric trauma patients with serious head injuries: Report

Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.

9 Jul 2010

Phase II trial results of TB-402 presented at International Congress on Thrombosis

BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

9 Jul 2010

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Texas Health Presbyterian Hospital Dallas is the first hospital in Texas — and one of only three in the United States — to be named a Center of Excellence for gynecological surgery by the American Institute for Minimally Invasive Surgery.

9 Jul 2010

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Phase I clinical data for BAY86-6150, a novel recombinant factor VIIa protein (rFVIIa) being developed by Bayer HealthCare, will be presented at the XXIX International Congress of the World Federation of Hemophilia (WFH) to be held in Buenos Aires, Argentina from Saturday, July 10-Wednesday, July 14.

9 Jul 2010

Ethicon launches OMNEX Surgical synthetic sealant

Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in vascular reconstructions by mechanically sealing areas of leakage. The US Food and Drug Administration (FDA) recently granted approval of the Premarket Approval Application (PMA) for ETHICON™ OMNEX™ Surgical Sealant.

8 Jul 2010

Nation's emergency physicians urge parents to be aware of playground injuries

Summer for many Americans is a time for outdoor activities, including trips to playgrounds with children. The nation's emergency physicians encourage everyone to have fun and stay active in parks and playgrounds throughout the summer, but urge parents and guardians of children to be aware of injuries that can occur in a matter of seconds if everyone's not careful.

7 Jul 2010

AUGIB patients more likely to suffer further bleeding with early red blood cell transfusion

Doctors have called for an urgent review of transfusion policies after a UK-wide study of over 200 hospitals found that patients admitted with acute upper gastrointestinal bleeding (AUGIB) are more than twice as likely to suffer further bleeding if they receive a red blood cell transfusion within 12 hours.

7 Jul 2010

ASPREE study aims to assess health benefits of aspirin

In an effort to extend the length of a disability-free life for older adults, researchers from Rush University Medical Center are partnering with colleagues from across the U.S. and Australia in the largest international trial ever sponsored by the National Institute on Aging.

7 Jul 2010

Extended treatment with blood thinner benefits patients immobilized by acute medical illness: Study

A treatment plan used to prevent potentially dangerous blood clots in recovering surgical patients can also benefit some patients immobilized by acute medical illness, doctors have found in a multi-institutional study.

7 Jul 2010

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a promising option for patients with treatment-resistant chronic lymphocytic leukemia (CLL), regardless of the patient's underlying genetic abnormalities, according to the results of a study published online today in Blood, the journal of the American Society of Hematology.

2 Jul 2010

Follicle aspiration needle Swemed Sense gives less pain, bleeding compared with conventional needle

“The follicle aspiration needle Swemed Sense™ makes it possible to work in a new way, which is more favourable for patients, and at the same time it meets all the other quality requirements for a follicle aspiration needle”

1 Jul 2010

Collaborative project to consider new hypotheses for causation of subdural hematomas in SBS

New research led by the East Midlands Forensic Pathology Unit at the University of Leicester will consider new theories as to the cause of subdural hematomas in infants. Support for the research has been provided by the NPIA, and the project is multi-disciplinary and collaborative.

1 Jul 2010

Judge rules for Merck in state Vioxx lawsuit over Medicaid payments

A federal judge ruled in favor of Merck & Co. Tuesday in a lawsuit brought by Louisiana trying to recoup what it paid when Medicaid patients used the company's withdrawn painkiller Vioxx, The Associated Press reports. James R. Dugan II, "the lead attorney representing Louisiana, said his team would be meeting with state officials later this week to discuss appellate possibilities.

1 Jul 2010

Bleeding News and Research

Stimulation of single whisker prevents stroke in rats

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Bayer HealthCare announces over $2.5M for largest awards program in hemophilia

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Serum BNP do not increase in pediatric trauma patients with serious head injuries: Report

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Bayer HealthCare to present BAY86-6150 rFVIIa Phase I clinical data at XXIX WFH International Congress

Ethicon launches OMNEX Surgical synthetic sealant

Nation's emergency physicians urge parents to be aware of playground injuries

AUGIB patients more likely to suffer further bleeding with early red blood cell transfusion

ASPREE study aims to assess health benefits of aspirin

Extended treatment with blood thinner benefits patients immobilized by acute medical illness: Study

Allogeneic stem cell transplant holds promise for treatment-resistant chronic lymphocytic leukemia

Follicle aspiration needle Swemed Sense gives less pain, bleeding compared with conventional needle

Collaborative project to consider new hypotheses for causation of subdural hematomas in SBS

Judge rules for Merck in state Vioxx lawsuit over Medicaid payments

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News